EQ Equillium, Inc. - Common Stock
$2,32
Kurs · Aug 20, 2026
Fundamentaldaten per Aug 13, 2026
52W-Spanne
$1–$4
56% of range
Analystenbewertung
BUY
18 analysts
Kursziel
$9
+269% upside
P/E (TTM)
-5.9
ROE
-133.1%
Nettogewinnmarge
—
EQ Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.32
Marktkapitalisierung
$143M
P/E (TTM)
-5.9
EPS (TTM)
$-0.39
Umsatz (TTM)
$41M
Dividendenrendite
—
ROE
-133.1%
Verschuldungsgrad
—
52W-Spanne
$1 – $4
EQ Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$41M
2022-12-31
→
2024-12-31
EPS
$-0.39
2021-12-31
→
2025-12-31
Freier Cashflow
$-23M
2018-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
EQ
Peer-Median
P/E (TTM)
-5.9
—
P/S (TTM) (K/V (TTM))
3.1
28.5
P/B (K/B)
5.0
2.2
Price / FCF (Kurs / FCF)
-6.3
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
EQ
Peer-Median
ROA
-77.9%
-100.0%
ROE
-133.1%
-154.7%
ROIC
-82.7%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
EQ
Peer-Median
Current Ratio (Liquiditätsgrad)
10.6
2.9
Quick Ratio
10.3
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
EQ
Peer-Median
Revenue YoY (Umsatz YoY)
13.9%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
EQ
Peer-Median
EQ Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
18 Analysten
- Starker Kauf 8 44,4%
- Kauf 9 50,0%
- Halten 1 5,6%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
9 Analysten · 2026-08-17
Median
$7.00
Mittelwert
$8.56
← Unter allen Zielen
$2.32
Tief
$4.00
Hoch
$20.00
Median-Ziel
$7.00
+201,7%
Mittelwert-Ziel
$8.56
+268,8%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.07%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.06 | $-0.04 | -0.02% |
| 31. Dezember 2025 | $-0.04 | $-0.06 | 0.02% |
| 30. September 2025 | $-0.06 | $-0.15 | 0.09% |
| 30. Juni 2025 | $-0.16 | $-0.19 | 0.03% |
| 31. März 2025 | $-0.24 | $-0.35 | 0.11% |
| 31. Dezember 2024 | $-0.16 | $-0.32 | 0.16% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| EQ | $95M | -4.0 | 13.9% | — | -133.1% | — |
| UNCY | $128M | -3.5 | -29.0% | — | -113.9% | — |
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | — |
| SPRB | $120M | -1.7 | -51.3% | — | -139.9% | — |
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| HURA | — | -1.2 | — | — | — | — |
| CBUS | — | -0.6 | -14.6% | -3492.3% | -223.0% | — |
| INO | $120M | -1.0 | -70.0% | -130000.0% | -322.8% | — |
| CYPH | $97M | 16.6 | — | — | 6.1% | — |
| VTVT | — | — | — | — | -70.4% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | · | $41M | $36M | $16M | |
| R&D Expense | · | · | $37M | $38M | |
| SG&A Expense | $11M | $12M | $14M | $17M | |
| Operating Expenses | $24M | $49M | $51M | $78M | |
| Operating Income | $-24M | $-8M | $-15M | $-62M | |
| Interest Income | $833.0K | $1M | $2M | $420.0K | |
| Other Non-op | · | · | $-76.0K | $281.0K | |
| Pretax Income | $-22M | $-8M | $-13M | $-62M | |
| Income Tax | $0 | $361.0K | $580.0K | $0 | |
| Net Income | $-22M | $-8M | $-13M | $-62M | |
| EPS (Basic) | $-0.39 | $-0.23 | $-0.38 | $-1.85 | |
| EPS (Diluted) | $-0.39 | $-0.23 | $-0.38 | $-1.85 | |
| Shares (Basic) | 57,304,181 | 35,357,641 | 34,726,384 | 33,727,945 | |
| Shares (Diluted) | 57,304,181 | 35,357,641 | 34,726,384 | 33,727,945 | |
| EBITDA | $-24M | $-8M | $-15M | $-62M |
Bilanz 23
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $18M | $23M | $59M | |
| Receivables | · | $0 | $4M | $3M | |
| Prepaid Expense | $761.0K | $2M | $5M | $3M | |
| Other Current Assets | $214.0K | $429.0K | $235.0K | $8.0K | |
| Current Assets | $31M | $25M | $49M | $77M | |
| PP&E (Net) | $164.0K | $262.0K | $315.0K | $391.0K | |
| Accum. Depreciation | $562.0K | $499.0K | $364.0K | $249.0K | |
| Other Non-current Assets | $27.0K | · | $70.0K | $104.0K | |
| Total Assets | $32M | $26M | $51M | $78M | |
| Accounts Payable | $755.0K | $3M | $5M | $4M | |
| Accrued Liabilities | $2M | $3M | $7M | $7M | |
| Short-term Debt | · | · | · | $6M | |
| Current Liabilities | $3M | $6M | $28M | $32M | |
| Capital Leases | $356.0K | $187.0K | $384.0K | $824.0K | |
| Total Liabilities | $3M | $7M | $28M | $46M | |
| Long-term Debt | · | · | · | $9M | |
| Total Debt | · | · | · | $15M | |
| Common Stock | $5.0K | $3.0K | $3.0K | $3.0K | |
| Retained Earnings | $-216M | $-194M | $-186M | $-172M | |
| AOCI | $363.0K | $781.0K | $140.0K | $76.0K | |
| Stockholders' Equity | $29M | $19M | $23M | $32M | |
| Liabilities + Equity | $32M | $26M | $51M | $78M | |
| Shares Outstanding | 61,464,368 | 35,557,563 | 35,254,752 | 34,414,149 |
Cashflow 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | · | · | · | $118.0K | |
| Stock-based Comp | $2M | $4M | $4M | $5M | |
| Deferred Tax | · | · | · | $0 | |
| Operating Cash Flow | $-23M | $-19M | $-22M | $-9M | |
| CapEx | $48.0K | $85.0K | $50.0K | $279.0K | |
| Investing Cash Flow | $4M | $14M | $-5M | $19M | |
| Stock Repurchased | · | · | $260.0K | · | |
| Net Stock Activity | · | · | $-260.0K | · | |
| Financing Cash Flow | $30M | $164.0K | $-9M | $-1M | |
| Net Change in Cash | $12M | $-5M | $-36M | $9M | |
| Taxes Paid | $352.0K | · | · | · | |
| Free Cash Flow | $-23M | $-19M | $-22M | $-9M |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | · | -20.1% | -40.2% | -393.9% | |
| Net Margin | · | -19.6% | -37.0% | -396.1% | |
| Pretax Margin | · | -18.8% | -35.4% | -396.1% | |
| EBITDA Margin | · | -20.1% | -40.2% | -393.9% | |
| ROA | -77.9% | -21.2% | -20.7% | -76.2% | |
| ROE | -133.1% | -38.2% | -57.1% | -207.7% | |
| ROIC | -82.7% | -45.4% | -67.3% | -133.2% |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 10.6 | 3.9 | 1.8 | 2.4 | |
| Quick Ratio | 10.3 | 2.8 | 1.0 | 1.9 | |
| Debt / Equity | · | · | · | 0.5 | |
| LT Debt / Equity | · | · | · | 0.1 |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | · | 1.1 | 0.6 | 0.2 | |
| Receivables Turnover | · | 22.0 | 11.0 | 11.1 |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | · | 13.9% | 129.0% | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $46M | $41M | $36M | $16M | |
| Net Income TTM | $-22M | $-8M | $-13M | $-62M | |
| Market Cap | $95M | $27M | $25M | $36M | |
| Enterprise Value | · | · | · | $-8M | |
| P/E | -4.0 | -3.3 | -1.9 | -0.6 | |
| P/S | 2.1 | 0.6 | 0.7 | 2.3 | |
| P/B | 3.3 | 1.4 | 1.1 | 1.1 | |
| P / Tangible Book | 3.3 | 1.4 | 1.1 | 1.1 | |
| P / Cash Flow | -4.2 | -1.4 | -1.2 | -4.2 | |
| P / FCF | -4.2 | -1.4 | -1.2 | -4.0 | |
| EV / EBITDA | · | · | · | 0.1 | |
| EV / FCF | · | · | · | 0.9 | |
| EV / Revenue | · | · | · | -0.5 | |
| Earnings Yield | -25.2% | -30.7% | -52.8% | -174.5% |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $4M | $12M | $14M | $11M | $9M | $9M | $9M | $9M | |
| SG&A Expense | $2M | $3M | $2M | $3M | $2M | $3M | $2M | $3M | $3M | $4M | $3M | $4M | $3M | $4M | |
| Operating Expenses | $5M | $6M | $4M | $5M | $6M | $9M | $9M | $13M | $14M | $13M | $12M | $12M | $13M | $13M | |
| Operating Income | $-5M | $-6M | $-4M | $-5M | $-6M | $-9M | $-5M | $-679.0K | $-100.0K | $-3M | $-3M | $-4M | $-4M | $-4M | |
| Interest Income | $509.0K | $309.0K | $303.0K | $235.0K | $122.0K | $173.0K | $240.0K | $331.0K | $371.0K | $439.0K | $517.0K | $551.0K | $627.0K | $639.0K | |
| Other Non-op | · | · | · | · | · | · | · | · | · | $-382.0K | · | $-142.0K | $-112.0K | $-179.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | $-3M | $-2M | $-3M | $-3M | $-4M | |
| Income Tax | · | · | $0 | $0 | $0 | $0 | $361.0K | $0 | $0 | $0 | $16.0K | $496.0K | $8.0K | $60.0K | |
| Net Income | $-5M | $-5M | $-4M | $-4M | $-6M | $-9M | $-6M | $-7.0K | $468.0K | $-3M | $-2M | $-4M | $-3M | $-4M | |
| EPS (Basic) | $-0.04 | $-0.06 | $0.07 | $-0.06 | $-0.16 | $-0.24 | $-0.16 | $0.00 | $0.01 | $-0.08 | $-0.06 | $-0.11 | $-0.10 | $-0.11 | |
| EPS (Diluted) | $-0.04 | $-0.06 | $0.07 | $-0.06 | $-0.16 | $-0.24 | $-0.16 | $0.00 | $0.01 | $-0.08 | $-0.06 | $-0.11 | $-0.10 | $-0.11 | |
| Shares (Basic) | 111,805,635 | 96,279,216 | -79,324,750 | 65,322,753 | 35,719,317 | 35,586,861 | -70,613,534 | 35,424,388 | 35,292,035 | 35,254,752 | -69,016,234 | 34,878,700 | 34,449,769 | 34,414,149 | |
| Shares (Diluted) | 111,805,635 | 96,279,216 | -79,324,750 | 65,322,753 | 35,719,317 | 35,586,861 | -71,911,273 | 35,424,388 | 36,589,774 | 35,254,752 | -69,016,234 | 34,878,700 | 34,449,769 | 34,414,149 | |
| EBITDA | $-5M | $-6M | · | $-5M | $-6M | $-9M | · | $-679.0K | $-100.0K | $-3M | · | $-4M | $-4M | $-4M |
Bilanz 23
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57M | $61M | $30M | $33M | $11M | $15M | $18M | $15M | $11M | $12M | $23M | $34M | $26M | $25M | |
| Receivables | · | · | · | · | · | · | · | $5M | $6M | $5M | $4M | $4M | $4M | $3M | |
| Prepaid Expense | $812.0K | $953.0K | $761.0K | $459.0K | $457.0K | $2M | $2M | $3M | $3M | $5M | $5M | $4M | $5M | $5M | |
| Other Current Assets | · | · | $214.0K | $110.0K | $37.0K | $36.0K | $429.0K | $381.0K | $317.0K | $275.0K | $235.0K | · | · | · | |
| Current Assets | $58M | $62M | $31M | $34M | $12M | $16M | $25M | $34M | $42M | $42M | $49M | $54M | $57M | $70M | |
| PP&E (Net) | $188.0K | $214.0K | $164.0K | $174.0K | $201.0K | $233.0K | $262.0K | $293.0K | $329.0K | $361.0K | $315.0K | $313.0K | $329.0K | $360.0K | |
| Accum. Depreciation | · | · | $562.0K | · | · | · | $499.0K | · | · | · | $364.0K | · | · | · | |
| Other Non-current Assets | $27.0K | $27.0K | $27.0K | · | · | · | · | $45.0K | $53.0K | $62.0K | $70.0K | $79.0K | $87.0K | $96.0K | |
| Total Assets | $59M | $63M | $32M | $35M | $12M | $17M | $26M | $34M | $43M | $44M | $51M | $55M | $59M | $72M | |
| Accounts Payable | $850.0K | $1M | $755.0K | $1M | $5M | $3M | $3M | $4M | $4M | $3M | $5M | $4M | $3M | $6M | |
| Accrued Liabilities | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $5M | $7M | $6M | $7M | $8M | $8M | $5M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Current Liabilities | $2M | $3M | $3M | $3M | $7M | $6M | $6M | $11M | $20M | $22M | $28M | $28M | $25M | $32M | |
| Capital Leases | $172.0K | $251.0K | $356.0K | $473.0K | $109.0K | $149.0K | $187.0K | $223.0K | $259.0K | $295.0K | $384.0K | $498.0K | $609.0K | $719.0K | |
| Total Liabilities | $3M | $4M | $3M | $4M | $7M | $6M | $7M | $11M | $20M | $23M | $28M | $31M | $32M | $43M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $8M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $13M | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Retained Earnings | $-226M | $-222M | $-216M | $-212M | $-208M | $-202M | $-194M | $-188M | $-188M | $-188M | $-186M | $-183M | $-180M | $-176M | |
| AOCI | $381.0K | $370.0K | $363.0K | $270.0K | $385.0K | $731.0K | $781.0K | $-3.0K | $251.0K | $423.0K | $140.0K | $458.0K | $340.0K | $305.0K | |
| Stockholders' Equity | $56M | $59M | $29M | $31M | $5M | $11M | $19M | $23M | $22M | $21M | $23M | $24M | $27M | $29M | |
| Liabilities + Equity | $59M | $63M | $32M | $35M | $12M | $17M | $26M | $34M | $43M | $44M | $51M | $55M | $59M | $72M | |
| Shares Outstanding | 63,408,082 | 63,226,556 | 61,464,368 | 60,676,837 | 35,719,317 | 35,719,317 | 35,557,563 | 35,424,388 | 35,424,388 | 35,254,752 | 35,254,752 | 35,119,248 | 34,568,500 | 34,414,149 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $31.0K | $31.0K | $31.0K | |
| Stock-based Comp | $1M | $930.0K | $737.0K | $401.0K | $563.0K | $621.0K | $821.0K | $1M | $952.0K | $972.0K | $1M | $979.0K | $934.0K | $1M | |
| Operating Cash Flow | $-4M | $-4M | $-3M | $-8M | $-3M | $-8M | $-3M | $-8M | $730.0K | $-9M | $-6M | $-2M | $-6M | $-8M | |
| CapEx | $71.0K | $3.0K | $44.0K | $0 | $0 | $4.0K | $4.0K | $0 | $62.0K | $19.0K | $35.0K | · | · | · | |
| Investing Cash Flow | $-71.0K | $-3.0K | $-32.0K | $0 | $0 | $4M | $6M | $12M | $-1M | $-3M | $-6M | $11M | $15M | $-25M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Financing Cash Flow | $42.0K | $35M | $283.0K | $30M | $-16.0K | $91.0K | $73.0K | $0 | · | · | $79.0K | $-260.0K | $-8M | $-1M | |
| Net Change in Cash | $-4M | $31M | $-3M | $22M | $-3M | $-4M | $3M | $4M | $-511.0K | $-12M | $-11M | $9M | $1M | $-35M | |
| Free Cash Flow | · | $-4M | · | · | · | $-8M | · | · | · | $-9M | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | -5.6% | -0.72% | -26.1% | · | -40.8% | -39.4% | -46.3% | |
| Net Margin | · | · | · | · | · | · | · | -0.06% | 3.4% | -25.6% | · | -41.8% | -36.6% | -44.4% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | -25.6% | · | -36.2% | -36.5% | -43.7% | |
| EBITDA Margin | · | · | · | · | · | · | · | -5.6% | -0.72% | -26.1% | · | -40.8% | -39.4% | -46.3% | |
| ROA | -13.2% | -13.3% | · | -12.3% | -20.8% | -28.7% | · | -0.02% | 0.92% | -4.7% | · | -7.1% | -5.5% | -5.4% | |
| ROE | -15.4% | -15.2% | · | -15.6% | -41.8% | -54.6% | · | -0.03% | 1.9% | -10.9% | · | -14.2% | -9.9% | -9.6% | |
| ROIC | · | · | · | · | · | · | · | · | · | -13.2% | · | -17.3% | -13.3% | -9.8% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 23.4 | 18.6 | · | 10.9 | 1.7 | 2.7 | · | 3.0 | 2.1 | 1.9 | · | 1.9 | 2.3 | 2.2 | |
| Quick Ratio | 23.1 | 18.3 | · | 10.7 | 1.6 | 2.4 | · | 1.9 | 0.8 | 0.7 | · | 1.4 | 1.2 | 0.9 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.5 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.1 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.1 | |
| Receivables Turnover | · | · | · | · | · | · | · | 2.8 | 2.9 | 2.5 | · | 4.7 | 4.9 | 5.2 |
Bewertung (TTM) 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $46M | $46M | · | $46M | $46M | $46M | · | $46M | $43M | $38M | · | · | · | · | |
| Net Income TTM | $-20M | $-24M | · | $-19M | $-14M | $-11M | · | $-6M | $-9M | $-14M | · | $-25M | $-35M | $-69M | |
| Market Cap | $203M | $126M | · | $87M | $11M | $14M | · | $29M | $24M | $81M | · | $26M | $26M | $25M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | $14M | |
| P/E | -10.0 | -3.8 | · | -3.1 | -0.8 | -1.3 | · | -4.6 | -2.5 | -5.8 | · | -1.0 | -0.7 | -0.3 | |
| P/S | 4.5 | 2.8 | · | 1.9 | 0.3 | 0.3 | · | 0.6 | 0.6 | 2.2 | · | · | · | · | |
| P/B | 3.6 | 2.1 | · | 2.8 | 2.3 | 1.3 | · | 1.3 | 1.1 | 3.9 | · | 1.1 | 1.0 | 0.9 | |
| P / Tangible Book | 3.6 | 2.1 | · | 2.8 | 2.3 | 1.3 | · | 1.3 | 1.1 | 3.9 | · | 1.1 | 1.0 | 0.9 | |
| P / Cash Flow | · | -29.4 | · | · | · | -1.7 | · | · | · | -9.3 | · | · | · | -3.1 | |
| P / FCF | · | -29.4 | · | · | · | -1.7 | · | · | · | -9.2 | · | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | · | -3.4 | |
| Earnings Yield | -10.0% | -26.0% | · | -32.2% | -121.9% | -79.5% | · | -21.7% | -40.6% | -17.3% | · | -97.3% | -136.0% | -286.3% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | — | $41M | $36M | $16M | — |
| Betriebsgewinnmarge % | — | -20.1% | -40.2% | -393.9% | — |
| Nettoergebnis | $-22M | $-8M | $-13M | $-62M | $-39M |
| Verwässerte EPS | $-0.39 | $-0.23 | $-0.38 | $-1.85 | $-1.36 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | — | — | — | 0.5 | 0.2 |
| Liquiditätsgrad | 10.6 | 3.9 | 1.8 | 2.4 | 9.4 |
| Quick Ratio | 10.3 | 2.8 | 1.0 | 1.9 | 5.6 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-23M | $-19M | $-22M | $-9M | $-32M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 71 Einreicher · $130.2M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 20 (0 vs. Vorquartal) | 8 (+5 vs. Vorquartal) | 16 (+7 vs. Vorquartal) | 17 (+5 vs. Vorquartal) | -5.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Decheng Capital LLC | $14.231.386 | 4.447.308 | 10,93% | Aktien |
| Affinity Asset Advisors, LLC | $13.120.000 | 4.100.000 | 10,07% | Aktien |
| JANUS HENDERSON GROUP PLC | $12.956.669 | 6.494.571 | 9,95% | Aktien |
| ADAR1 Capital Management, LLC | $12.027.421 | 3.758.569 | 9,23% | Aktien |
| Aberdeen Group plc | $11.621.309 | 3.631.659 | 8,92% | Aktien |
| Woodline Partners LP | $11.202.883 | 3.500.901 | 8,60% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $9.908.275 | 3.096.336 | 7,61% | Aktien |
| STEMPOINT CAPITAL LP | $6.453.142 | 2.016.607 | 4,95% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.832.998 | 1.822.812 | 4,48% | Aktien |
| Eversept Partners, LP | $4.866.637 | 1.520.824 | 3,74% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4.448.810 | 1.390.253 | 3,42% | Aktien |
| VANGUARD GROUP INC | $2.673.854 | 1.725.067 | 2,05% | Aktien |
| TAKEDA PHARMACEUTICAL CO LTD | $2.609.717 | 1.824.977 | 2,00% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $2.040.374 | 637.617 | 1,57% | Aktien |
| Exome Asset Management LLC | $1.769.459 | 552.956 | 1,36% | Aktien |
| DG Capital Management, LLC | $1.482.867 | 463.396 | 1,14% | Aktien |
| DIADEMA PARTNERS LP | $1.280.902 | 400.282 | 0,98% | Aktien |
| Balyasny Asset Management L.P. | $1.102.109 | 344.409 | 0,85% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $1.024.320 | 320.100 | 0,79% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $994.780 | 310.682 | 0,76% | Aktien |
| Ikarian Capital, LLC | $971.376 | 303.555 | 0,75% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $909.856 | 284.330 | 0,70% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $661.930 | 206.853 | 0,51% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $610.592 | 190.810 | 0,47% | Aktien |
| STATE STREET CORP | $556.992 | 174.060 | 0,43% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $478.080 | 149.400 | 0,37% | Verkaufsoption |
| CANTOR FITZGERALD, L. P. | $348.998 | 109.062 | 0,27% | Aktien |
| Persistent Asset Partners Ltd | $326.432 | 102.010 | 0,25% | Aktien |
| CITADEL ADVISORS LLC | $318.918 | 99.662 | 0,24% | Aktien |
| Soleus Capital Management, L.P. | $288.000 | 90.000 | 0,22% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $237.632 | 74.260 | 0,18% | Aktien |
| NORTHERN TRUST CORP | $228.989 | 71.559 | 0,18% | Aktien |
| Cota Capital Management, LLC | $177.230 | 562.278 | 0,14% | Aktien |
| AlphaCore Capital LLC | $167.504 | 52.345 | 0,13% | Aktien |
| JANE STREET GROUP, LLC | $149.440 | 46.700 | 0,11% | Verkaufsoption |
| ExodusPoint Capital Management, LP | $141.405 | 44.189 | 0,11% | Aktien |
| JANE STREET GROUP, LLC | $141.120 | 44.100 | 0,11% | Kaufoption |
| MILLENNIUM MANAGEMENT LLC | $137.082 | 42.838 | 0,11% | Aktien |
| XTX Topco Ltd | $125.642 | 39.263 | 0,10% | Aktien |
| Invesco Ltd. | $116.131 | 36.291 | 0,09% | Aktien |
| BARCLAYS PLC | $112.000 | 35.000 | 0,09% | Aktien |
| JANE STREET GROUP, LLC | $111.926 | 34.977 | 0,09% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $111.040 | 34.700 | 0,09% | Kaufoption |
| Jefferies Financial Group Inc. | $109.120 | 34.100 | 0,08% | Aktien |
| High Net Worth Advisory Group LLC | $107.200 | 33.500 | 0,08% | Aktien |
| CITIGROUP INC | $104.624 | 32.695 | 0,08% | Aktien |
| Quadrature Capital Ltd | $91.696 | 28.655 | 0,07% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $82.864 | 25.895 | 0,06% | Aktien |
| China Universal Asset Management Co., Ltd. | $80.000 | 25.000 | 0,06% | Aktien |
| TWO SIGMA ADVISERS, LP | $68.355 | 44.100 | 0,05% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $67.875 | 21.211 | 0,05% | Aktien |
| Chung Wu Investment Group, LLC | $52.800 | 16.500 | 0,04% | Aktien |
| CITADEL ADVISORS LLC | $52.480 | 16.400 | 0,04% | Verkaufsoption |
| DIMENSIONAL FUND ADVISORS LP | $49.066 | 15.333 | 0,04% | Aktien |
| Coastal Bridge Advisors, LLC | $48.000 | 15.000 | 0,04% | Aktien |
| Apollon Wealth Management, LLC | $44.400 | 13.875 | 0,03% | Aktien |
| Focus Partners Wealth | $41.642 | 13.013 | 0,03% | Aktien |
| Callan Capital, LLC | $39.108 | 99.688 | 0,03% | Aktien |
| TWO SIGMA SECURITIES, LLC | $34.550 | 10.797 | 0,03% | Aktien |
| BlackRock, Inc. | $31.552 | 9.860 | 0,02% | Aktien |
| Vanguard Global Advisers, LLC | $18.643 | 5.826 | 0,01% | Aktien |
| MORGAN STANLEY | $17.162 | 5.363 | 0,01% | Aktien |
| Tower Research Capital LLC (TRC) | $7.632 | 2.385 | 0,01% | Aktien |
| GROUP ONE TRADING LLC | $7.162 | 2.238 | 0,01% | Aktien |
| WELLS FARGO & COMPANY/MN | $3.200 | 1.000 | 0,00% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $1.525 | 500 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $749 | 234 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $218 | 68 | 0,00% | Aktien |
| UBS Group AG | $128 | 40 | 0,00% | Aktien |
| HRT FINANCIAL LP | $86 | 26.978 | 0,00% | Aktien |
| HUNTINGTON NATIONAL BANK | $42 | 1 | 0,00% | Aktien |
Unternehmensinsider 16 Insider · 9 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Bruce D. Steel | President and CEO | 2. Januar 2024 A | 48.495 | 0 | 0 | $0 |
| Jason A Keyes | Chief Financial Officer | 2. Januar 2024 A | 58.913 | 0 | 0 | $0 |
| Stephen Connelly | President and CSO | 4. Juni 2026 S | 762.025 | 0 | 1 | $-632.760 |
| Christine Zedelmayer | Sr. Vice President and COO | 5. Juni 2026 M | 62.586 | 0 | 2 | $-69.254 |
| Penny Tom | Principal Accounting Officer | 28. Mai 2026 M | 0 | 0 | 1 | $-191.750 |
| Daniel Bradbury | CHAIRMAN | 28. Mai 2026 A | 2.969.596 | 0 | 0 | $0 |
| Joel Rothman | Chief Development Officer | 2. Januar 2024 A | 58.150 | 0 | 0 | $0 |
| Dolca Thomas | Chief Medical Officer | 11. Januar 2021 A | — | 0 | 0 | $0 |
| Krishna R Polu | Chief Medical Officer | 22. April 2020 A | — | 0 | 0 | $0 |
| Charles Douglas Mcdermott | Direktor | 28. Mai 2026 A | — | 0 | 0 | $0 |
| Barbara Troupin | Direktor | 28. Mai 2026 A | — | 0 | 0 | $0 |
| Mark Pruzanski | Direktor | 28. Mai 2026 A | — | 0 | 0 | $0 |
| Martha J Demski | Direktor | 28. Mai 2026 A | — | 0 | 0 | $0 |
| Yu (Katherine) Xu | Direktor | 22. Mai 2023 A | — | 0 | 0 | $0 |
| Bala S Manian | Direktor | 22. Mai 2023 A | — | 0 | 0 | $0 |
| Biocon SA | 10%-Eigentümer | 16. Oktober 2018 A | 2.316.134 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Decheng Capital Global Life Sciences Fund IV, L.P., Decheng Capital Management IV (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Xiangmin Cui | 16. Februar 2021 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 6 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,40% | 38.559 SH | 19. August 2026 | Täglich |
| IWC · iShares Trust | 0,02% | 149.641 SH | 19. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 10.623 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 7.665 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 373.367 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.401.958 SH | 19. August 2026 | Täglich |